MedTrace Logo

The Effect of Prophylactic Hemodialysis on the Morbidity and Mortality of the Patients With Chronic Kidney Disease Stages 3-4 Undergoing Coronary Artery Graft Bypass

NCT01410617 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2013-03-27

No results posted yet for this study

Summary

Coronary artery disease is a major cause of death in patients with renal dysfunction Among patients who undergo coronary artery bypass grafting ,renal dysfunction is known To be a major predictor of in-hospital and remote mortality As little is known about the impact of non-dialysis-dependent renal dysfunction on short and mid term Outcomes following coronary surgery we have decided to investigate the effect of prophylactic Hemodialysis on the mortality and morbidity of the patients with ckd (stage 3,4 ) and compare these Effect with the control group

Conditions

Interventions

PROCEDURE

hemodialysis

3 sessions hemodialysis before CABG

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    collaborator OTHER

  • Imam Khomeini Hospital

    lead OTHER

Principal Investigators

  • Roghieh Borji, MD · Imam Khomeini Hospital

  • Mohammad R Khatami, MD · Nephrology research Center

  • Seyyed Hossein Ahmadi, MD · Tehran Herat Center

  • Khosro Barkhordari, MD · Tehran Heart Center

  • Mohammad R Abbasi, MD · Nephrology Researc Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-09-30
Completion
2013-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01410617 on ClinicalTrials.gov